AstraZeneca vs Continue

AstraZeneca (Data and AI: Unlocking new science insights) and Continue (Pioneering open-source coding agent) both appear on the Smoower Developer Ecosystem Index.

Continue (rank #189) holds a modest lead over AstraZeneca (rank #510) on the overall Smoower ecosystem score (50 vs 37). The gap of 13 points reflects composite signals across code, docs, community and reach.

On code quality (the state of repositories, tests, releases and polish), AstraZeneca is slightly ahead of Continue. On education (docs, guides and learning material for developers), Continue is slightly ahead of AstraZeneca. On community (issue response, PR reviews and discussion health), Continue is ahead of AstraZeneca. On reach (how visible the ecosystem is beyond its own repos), Continue is ahead of AstraZeneca. On momentum (release cadence and how fast the ecosystem moves), AstraZeneca is slightly ahead of Continue.

AstraZeneca carries 5,180 GitHub stars across 107 public repos, with 22 repositories active in the last 90 days and 2 external contributors on record. Continue shows 34,981 stars across 8 public repos, 3 active in the last 90 days and 136 external contributors. The star gap on its own does not decide the comparison, but Continue's footprint is roughly 6.8x larger, which usually shows up in downstream signals like inbound issues and third party integrations.

AstraZeneca is the stronger read for anyone weighting code quality. Continue looks better where reach is the deciding factor. The table below breaks the scores down pillar by pillar; the linked profiles cover the underlying repos, docs and community signals in full.